Literature DB >> 8827531

Effects of carboxy-terminal truncation on human lecithin:cholesterol acyltransferase activity.

O L Francone1, L Evangelista, C J Fielding.   

Abstract

Mutagenesis was carried out in human lecithin:cholesterol acyltransferase (LCAT) to generate mutants with stop codons at positions corresponding to amino acids 315, 341, 359, 375, 388, 394, and 398 of the 416-amino acid sequence of the mature enzyme protein. Deletion of the 18 terminal amino acids of the protein was without effect on LCAT phospholipase or acyltransferase activity, or the stability of the protein to denaturation at 37 degrees C. Further deletion led to loss of most of the activity, associated with a 10-fold increase in the rate of denaturation at 37 degrees C. These data indicate that the proline-rich C-terminus of LCAT is not required for effective enzyme activity. The loss of activity that accompanied deletion of residues 394-398 suggests a structural role for these residues, part of a series of predicted beta-sheet sequences in the C-terminal third of the LCAT primary sequence.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8827531

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  5 in total

1.  A retractable lid in lecithin:cholesterol acyltransferase provides a structural mechanism for activation by apolipoprotein A-I.

Authors:  Kelly A Manthei; Joomi Ahn; Alisa Glukhova; Wenmin Yuan; Christopher Larkin; Taylor D Manett; Louise Chang; James A Shayman; Milton J Axley; Anna Schwendeman; John J G Tesmer
Journal:  J Biol Chem       Date:  2017-10-13       Impact factor: 5.157

2.  A proposed architecture for lecithin cholesterol acyl transferase (LCAT): identification of the catalytic triad and molecular modeling.

Authors:  F Peelman; N Vinaimont; A Verhee; B Vanloo; J L Verschelde; C Labeur; S Seguret-Mace; N Duverger; G Hutchinson; J Vandekerckhove; J Tavernier; M Rosseneu
Journal:  Protein Sci       Date:  1998-03       Impact factor: 6.725

Review 3.  Lecithin: cholesterol acyltransferase--from biochemistry to role in cardiovascular disease.

Authors:  Xavier Rousset; Boris Vaisman; Marcelo Amar; Amar A Sethi; Alan T Remaley
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2009-04       Impact factor: 3.243

4.  Novel missense variants in LCAT and APOB genes in an Italian kindred with familial lecithin:cholesterol acyltransferase deficiency and hypobetalipoproteinemia.

Authors:  Paola Conca; Silvana Pileggi; Sara Simonelli; Emanuela Boer; Giuliano Boscutti; Lucia Magnolo; Patrizia Tarugi; Silvana Penco; Guido Franceschini; Laura Calabresi; Monica Gomaraschi
Journal:  J Clin Lipidol       Date:  2012-01-28       Impact factor: 4.766

Review 5.  PCSK9: A Potential Therapeutic Target for Sepsis.

Authors:  Yuan Yuan; Wei Wu; Shanshan Sun; Yi Zhang; Zhi Chen
Journal:  J Immunol Res       Date:  2020-10-14       Impact factor: 4.818

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.